文献速递呼吸衰竭与机械通气心脑血管急症消化、代谢与肾脏急症

SARS-CoV-2感染后6个月内的医疗服务利用

Health Care Utilization in the 6 Months Following SARS-CoV-2 Infection.
PubMed 文献 · JAMA Netw Open · 2022-08-01
一句话结论匹配回顾性队列显示,SARS-CoV-2阳性者6个月内医疗服务利用较阴性对照增加4%,主要为虚拟就诊和急诊就诊。

这项匹配回顾性队列纳入美国8个大型整合医疗系统2020年3月1日至11月1日完成SARS-CoV-2诊断检测的各年龄患者,按年龄、性别、种族和民族、地点及检测日期匹配,随访6个月。阳性组与阴性组各127859例;总体医疗服务利用增加4%(RRR 1.04 [95%CI 1.03-1.05]),以虚拟就诊(RRR 1.14 [95%CI 1.12-1.16])和急诊就诊(RRR 1.08 [95%CI 1.04-1.12])为主。18种PCC相关利用在急性期后6个月仍升高,估计额外增加27217次医疗接触(每1000例患者212.9次 [95%CI 146.5-278.4])。

要点

  • SARS-CoV-2阳性者6个月内总体医疗服务利用较阴性对照增加4%(RRR 1.04 [95%CI 1.03-1.05])。
  • 虚拟就诊增加14%(RRR 1.14 [95%CI 1.12-1.16]),急诊就诊增加8%(RRR 1.08 [95%CI 1.04-1.12])。
  • 18种PCC相关利用在急性期后6个月仍升高,包括脱发(RRR 2.52 [95%CI 2.17-2.92])、支气管炎(RRR 1.85 [95%CI 1.62-2.12])、肺栓塞或深静脉血栓(RRR 1.74 [95%CI 1.36-2.23])、呼吸困难(RRR 1.73 [95%CI 1.61-1.86])。
  • 估计6个月内额外增加27217次医疗接触,每1000例患者212.9次(95%CI 146.5-278.4)。
  • 研究覆盖美国8个大型整合医疗系统各年龄患者,提示PCC带来持续医疗负担。

适用人群与场景

  • 美国8个大型整合医疗系统内2020年3月1日至11月1日完成SARS-CoV-2诊断检测(包括逆转录聚合酶链反应和抗原检测)的各年龄患者。
  • 按年龄、性别、种族和民族、地点及SARS-CoV-2检测日期匹配,随访6个月。

研究设计与关键结果

  • 研究类型:匹配回顾性队列研究,来自美国8个大型整合医疗系统,纳入127859例SARS-CoV-2检测阳性患者和127859例检测阴性患者。
  • 人群特征:平均(SD)年龄41.2(18.6)岁,每组女性68696例(53.7%),每组西班牙裔66211例(51.8%)、非西班牙裔亚裔9122例(7.1%)、非西班牙裔黑人7983例(6.2%)、非西班牙裔白人34326例(26.9%)。
  • 主要终点:SARS-CoV-2感染与6个月内医疗服务利用增加4%相关(RRR 1.04 [95%CI 1.03-1.05])。
  • 按医疗场景:虚拟就诊RRR 1.14(95%CI 1.12-1.16),急诊就诊RRR 1.08(95%CI 1.04-1.12)。
  • 18种PCC相关利用在急性期后6个月仍升高:感染性疾病后遗症RRR 86.00(95%CI 5.07-1458.33),COVID-19 RRR 19.47(95%CI 10.47-36.22),脱发RRR 2.52(95%CI 2.17-2.92),支气管炎RRR 1.85(95%CI 1.62-2.12),肺栓塞或深静脉血栓RRR 1.74(95%CI 1.36-2.23),呼吸困难RRR 1.73(95%CI 1.61-1.86)。
  • 超额医疗利用:6个月内估计额外增加27217次医疗接触(每1000例患者212.9次 [95%CI 146.5-278.4])。

证据类型、等级与局限

  • 证据类型:匹配回顾性队列研究,采用双重差分分析和泊松回归模型计算率比之比(RRR)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 这项队列研究记录了急性感染后6个月PCC带来的超额医疗负担,数据可用于为既往SARS-CoV-2感染患者长期战略资源配置提供信息。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: After SARS-CoV-2 infection, many patients present with persistent symptoms for at least 6 months, collectively termed post-COVID conditions (PCC). However, the impact of PCC on health care utilization has not been well described.

OBJECTIVES: To estimate COVID-19-associated excess health care utilization following acute SARS-CoV-2 infection and describe utilization for select PCCs among patients who had positive SARS-CoV-2 test results (including reverse transcription-polymerase chain reaction and antigen tests) compared with control patients whose results were negative.

DESIGN, SETTING, AND PARTICIPANTS: This matched retrospective cohort study included patients of all ages from 8 large integrated health care systems across the United States who completed a SARS-CoV-2 diagnostic test during March 1 to November 1, 2020. Patients were matched on age, sex, race and ethnicity, site, and date of SARS-CoV-2 test and were followed-up for 6 months. Data were analyzed from March 18, 2021, to June 8, 2022.

EXPOSURE: SARS-CoV-2 infection.

MAIN OUTCOMES AND MEASURES: Ratios of rate ratios (RRRs) for COVID-19-associated health care utilization were calculated with a difference-in-difference analysis using Poisson regression models. RRRs were estimated overall, by health care setting, by select population characteristics, and by 44 PCCs. COVID-19-associated excess health care utilization was estimated by health care setting.

RESULTS: The final matched cohort included 127 859 patients with test results positive for SARS-CoV-2 and 127 859 patients with test results negative for SARS-CoV-2. The mean (SD) age of the study population was 41.2 (18.6) years, 68 696 patients in each group (53.7%) were female, and each group included 66 211 Hispanic patients (51.8%), 9122 non-Hispanic Asian patients (7.1%), 7983 non-Hispanic Black patients (6.2%), and 34 326 non-Hispanic White patients (26.9%). Overall, SARS-CoV-2 infection was associated with a 4% increase in health care utilization over 6 months (RRR, 1.04 [95% CI, 1.03-1.05]), predominantly for virtual encounters (RRR, 1.14 [95% CI, 1.12-1.16]), followed by emergency department visits (RRR, 1.08 [95% CI, 1.04-1.12]). COVID-19-associated utilization for 18 PCCs remained elevated 6 months from the acute stage of infection, with the largest increase in COVID-19-associated utilization observed for infectious disease sequelae (RRR, 86.00 [95% CI, 5.07-1458.33]), COVID-19 (RRR, 19.47 [95% CI, 10.47-36.22]), alopecia (RRR, 2.52 [95% CI, 2.17-2.92]), bronchitis (RRR, 1.85 [95% CI, 1.62-2.12]), pulmonary embolism or deep vein thrombosis (RRR, 1.74 [95% CI, 1.36-2.23]), and dyspnea (RRR, 1.73 [95% CI, 1.61-1.86]). In total, COVID-19-associated excess health care utilization amounted to an estimated 27 217 additional medical encounters over 6 months (212.9 [95% CI, 146.5-278.4] visits per 1000 patients).

CONCLUSIONS AND RELEVANCE: This cohort study documented an excess health care burden of PCC in the 6 months after the acute stage of infection. As health care systems evolve during a highly dynamic and ongoing global pandemic, these data provide valuable evidence to inform long-term strategic resource allocation for patients previously infected with SARS-CoV-2.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Tartof SY, Malden DE, Liu IA, et al. Health Care Utilization in the 6 Months Following SARS-CoV-2 Infection. JAMA Netw Open. 2022. PMID: 35960522. doi:10.1001/jamanetworkopen.2022.25657

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。